• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAQUET CARDIOPULMONARY AG OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAQUET CARDIOPULMONARY AG OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Inflammation (1932)
Event Date 01/31/2016
Event Type  malfunction  
Manufacturer Narrative
Update 03/18/2016 02:05 pm (b)(4): maquet medical systems, usa submits this report on behalf of the legal manufacturer of the device maquet cardiopulmonary (b)(4). The product was scrapped by the hospital; therefore manufacturer laboratory investigation was not possible. The complaint was determined to be potentially related to the medical device recall notice for hls set advanced dated february 23, 2016 in the us. This data will be handled trough a designated maquet trending process. If a trend occurs, it will be escalated to quality assurance management for review and determination if further investigation is necessary.
 
Event Description
Update 03/18/2016 02:10 pm ((b)(4)): it was reported a patient on ecls support was exhibiting what was believed were signs of an inflammatory response. They referenced the recent endotoxin letter and conveyed that the serial number on the quadrox-id oxygenator in use was noted in the letter. They expressed concern that the observations of this patient and the issue described in the letter may be related. Their primary concern was that the patient would be going to surgery on (b)(6) 2016 and they desired to have an oxygenator which was not included in the endotoxin letter. The exact product identity and lot# was not forwarded to the manufacturer yet. (b)(4).
 
Manufacturer Narrative
The quadrox-id oxygenator was returned to the factory and investigated. Due to the product being contaminated, only a visual inspection could be carried out. No blood clots were visible on either the blood inlet or outlet side of the oxygenator. The serial number / udi and the lot number of the oxygenator were photographically documented. Due to the high risk of infection posed by the disposable, it was disposed off appropriately after the visual inspection. The conclusion was that no clotting or any other anomalies could be established. A clinical assessment of this issue was carried out by the director for clinical risk management & documentation. Taking all the available information into account, he concluded that there is no indication that endotoxins from a maquet oxygenator is related to the state of the patient due to the following facts: 1)the patient had developed endocarditis prior to admission of the hospital. 2)elevated levels of d-dimers and fibrinogen is a typical finding in patients suffering from severe infections. 3), after the heart valve (source of infection) was resected and a new valve was placed, the patient recovered. Note: without ecmo and heart surgery, the patient would probably not have been able to survive; this was a successful treatment of an extremely sick patient. A correlation between elevated acute phase proteins and the maquet oxygenator cannot be confirmed.
 
Event Description
(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameOXYGENATOR, CARDIOPULMONARY BYPASS
Type of DeviceOXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
MAQUET CARDIOPULMONARY AG
rastatt
GM
Manufacturer (Section G)
BERND RAKOW
maquet cardiopulmonary ag
kehler strasse 31
76437 rastatt
GM
Manufacturer Contact
maquet cardiopulmonary ag
kehler strasse 31
76437 rastatt 
4972229321
MDR Report Key5513317
MDR Text Key41372698
Report Number8010762-2016-00198
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
PMA/PMN Number
K101153
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/26/2017
1 Device was Involved in the Event
0 Patients were Involved in the Event:
Date FDA Received03/21/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received03/03/2016
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

-
-